Assay for detection of early stage pancreatic cancer
US11693007B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2018 |
| Grant date | Jul 4, 2023 |
| Priority date | — |
| Expiry date | Oct 14, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57438
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are methods of detecting pancreatic cancer, particularly early stage pancreatic cancer, comprising measuring the expression of the biomarker panel TNC-FN III-C, TFPI, and CA19-9. The expression may be determined by an ELISA, such as a multiplex ELISA. Further provided herein are methods of treating subjects identified to have pancreatic cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.